Cardiac syndrome X is a heterogeneous condition with multifactorial pathogenesis that may benefit from a comprehensive treatment regimen including psychosocial and pharmacological interventions.
Answers are grounded in this paper and cite their sources.
Supports individualized regimens in cardiac syndrome X; leaves open optimal components pending prospective trials.
Cardiac syndrome X, the triad of angina pectoris, a positive exercise electrocardiogram for myocardial ischaemia and angiographically smooth coronary arteries, is frequently associated with debilitating symptomology, increased psychological morbidity and a poor quality of life. While various avenues of research have been undertaken, there are as yet no definitive conclusions regarding the exact pathogenesis of the condition. A number of physiological mechanisms have been explored, including the existence of underlying myocardial ischaemia, suggested endothelial dysfunction, abnormal pain perception, hormonal irregularities and insulin resistance, while the psychological impact of the condition has also been explored. Various treatment regimens have also been the subject of research with varying degrees of success. The heterogeneous nature of the patient population suggests that the mechanistic pathway may be multifactorial, while a comprehensive treatment regimen including both psychosocial and pharmacological interventions may offer the best outcome for patients with cardiac syndrome X.
No takes yet. Share an insight, caveat, or question.
Asbury et al. (2005) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: